Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cardinal Health Is Second Infusion Pump Maker To Be Hit By An FDA Seizure

This article was originally published in The Gray Sheet

Executive Summary

FDA's seizure of infusion pumps made by Cardinal Health was the agency's second such enforcement action against an infusion pump manufacturer in less than a year

Related Content

FDA To Impose New Pre-market Requirements On Infusion Pump Makers
CareFusion Mulls Relaunch Of Alaris SE After FDA Lifts Injunction
CareFusion Flies Solo: Flu Prep, Alaris Relaunch Aid First Earnings Report
Proposed Public-Private Safety Effort Would Target Poor Device Designs
Factoring In Human Factors: An Interview With Peter Carstensen
Cardinal’s Latest Infusion Pump Recall Could Take Months To Resolve
FDA Announces Two More Medical Device Consent Decrees
Smiths Medical infusion pump safety
FDA plans infusion pump workshops
Baxter’s Colleague Consent Decree Enjoins Sales, Expands Obligations



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts